Paper17869367
Liberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cells.
Malugin A and 2 others. J Control Release, 2007. Cited by 51 papers, by iCite.
Cite this record
ConductScience Library. Liberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cells. Papers, record 17869367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17869367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Liberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cells.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acrylamides | Major topic |
| Antibiotics, Antineoplastic | Major topic |
| Cell Cycle | Major topic |
| Cell Nucleus | Major topic |
| DNA Fragmentation | Major topic |
| Doxorubicin | Major topic |
| Ovarian Neoplasms | Major topic |
| Apoptosis | |
| Biological Availability | |
| Cell Line, Tumor | |
| Cell Survival | |
| Female | |
| Humans | |
| Microscopy, Confocal | |
| Microscopy, Fluorescence | |
| Molecular Structure |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 CA051578 | NCI NIH HHS | United States | R01CA051578 | PubMed and NIH |
| CA51578 | NCI NIH HHS | United States | R01CA051578 | PubMed and NIH |
Source NIH RePORTER
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11018556 | Time- and concentration-dependent apoptosis and necrosis induced by free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells. | J Control Release | 2000 | https://conductscience.org/library/papers/11018556 | PubMed |
| 2 | 11289131 | Cell surface-directed interaction of anthracyclines leads to cytotoxicity and nuclear factor kappaB activation but not apoptosis signaling. | Cancer Res | 2001 | https://conductscience.org/library/papers/11289131 | PubMed |
| 3 | 11295216 | Preliminary evaluation of caspases-dependent apoptosis signaling pathways of free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells. | J Control Release | 2001 | https://conductscience.org/library/papers/11295216 | PubMed |
| 4 | 11943391 | Differences in the intracellular fate of free and polymer-bound doxorubicin. | J Control Release | 2002 | https://conductscience.org/library/papers/11943391 | PubMed |
| 5 | 15380639 | HPMA copolymers containing doxorubicin bound by a proteolytically or hydrolytically cleavable bond: comparison of biological properties in vitro. | J Control Release | 2004 | https://conductscience.org/library/papers/15380639 | PubMed |
| 6 | 593972 | Soluble biomedical polymers. | Polim Med | 1977 | https://conductscience.org/library/papers/593972 | PubMed |
| 7 | 17402705 | The same drug but a different mechanism of action: comparison of free doxorubicin with two different N-(2-hydroxypropyl)methacrylamide copolymer-bound doxorubicin conjugates in EL-4 cancer cell line. | Bioconjug Chem | 2007 | https://conductscience.org/library/papers/17402705 | PubMed |
| 8 | 9741911 | Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate. | J Control Release | 1998 | https://conductscience.org/library/papers/9741911 | PubMed |
| 9 | 8866655 | HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 1. influence of the method of synthesis on the binding affinity to OVCAR-3 ovarian carcinoma cells in vitro. | J Drug Target | 1996 | https://conductscience.org/library/papers/8866655 | PubMed |
| 10 | 15981920 | HPMA copolymer-bound doxorubicin induces apoptosis in human ovarian carcinoma cells by a Fas-independent pathway. | Mol Pharm | 2004 | https://conductscience.org/library/papers/15981920 | PubMed |
| 11 | 16036307 | Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck. | J Drug Target | 2005 | https://conductscience.org/library/papers/16036307 | PubMed |
| 12 | 16247491 | Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. | Cell Death Differ | 2005 | https://conductscience.org/library/papers/16247491 | PubMed |
| 13 | 16269198 | Chemotherapy based on HPMA copolymer conjugates with pH-controlled release of doxorubicin triggers anti-tumor immunity. | J Control Release | 2005 | https://conductscience.org/library/papers/16269198 | PubMed |
| 14 | 16749867 | HPMA copolymer-bound doxorubicin induces apoptosis in ovarian carcinoma cells by the disruption of mitochondrial function. | Mol Pharm | 2006 | https://conductscience.org/library/papers/16749867 | PubMed |
| 15 | 16900224 | Polymer conjugates as anticancer nanomedicines. | Nat Rev Cancer | 2006 | https://conductscience.org/library/papers/16900224 | PubMed |
| 16 | 17092838 | Establishment of subcellular fractionation techniques to monitor the intracellular fate of polymer therapeutics I. Differential centrifugation fractionation B16F10 cells and use to study the intracellular fate of HPMA copolymer - doxorubicin. | J Drug Target | 2006 | https://conductscience.org/library/papers/17092838 | PubMed |
| 17 | 17092839 | HPMA based macromolecular therapeutics: internalization, intracellular pathway and cell death depend on the character of covalent bond between the drug and the peptidic spacer and also on spacer composition. | J Drug Target | 2006 | https://conductscience.org/library/papers/17092839 | PubMed |
| 18 | 17129632 | Investigating the mechanism of enhanced cytotoxicity of HPMA copolymer-Dox-AGM in breast cancer cells. | J Control Release | 2007 | https://conductscience.org/library/papers/17129632 | PubMed |
| 19 | 10728603 | Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma. | Int J Cancer | 2000 | https://conductscience.org/library/papers/10728603 | PubMed |
| 20 | 10699287 | Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. | J Control Release | 2000 | https://conductscience.org/library/papers/10699287 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42927187 | Spatiotemporal control of protein degradation: Advances in stimuli-responsive nano-PROTACs for precision cancer therapy. | Asian J Pharm Sci | 2026 | https://conductscience.org/library/papers/42927187 | PubMed |
| 40141443 | Gemcitabine-Doxorubicin Combination Polymer-Drug Conjugate Prepared by SPAAC Click Chemistry: In Vitro Characterization. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40141443 | PubMed |
| 39913003 | Pharmacogenomics influence on MDR1-associated cancer resistance and innovative drug delivery approaches: advancing precision oncology. | Med Oncol | 2025 | https://conductscience.org/library/papers/39913003 | PubMed |
| 38734315 | Hydrophilic biomaterials: From crosslinked and self-assembled hydrogels to polymer-drug conjugates and drug-free macromolecular therapeutics. | J Control Release | 2024 | https://conductscience.org/library/papers/38734315 | PubMed |
| 37765185 | Innovative Design of Targeted Nanoparticles: Polymer-Drug Conjugates for Enhanced Cancer Therapy. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37765185 | PubMed |
| 35629120 | Tumor Stimulus-Responsive Biodegradable Diblock Copolymer Conjugates as Efficient Anti-Cancer Nanomedicines. | J Pers Med | 2022 | https://conductscience.org/library/papers/35629120 | PubMed |
| 34359599 | Development of a Selective Tumor-Targeted Drug Delivery System: Hydroxypropyl-Acrylamide Polymer-Conjugated Pirarubicin (P-THP) for Pediatric Solid Tumors. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34359599 | PubMed |
| 33396604 | Synthesis and In Vitro Assessment of pH-Sensitive Human Serum Albumin Conjugates of Pirarubicin. | Pharmaceuticals (Basel) | 2020 | https://conductscience.org/library/papers/33396604 | PubMed |
| 32962018 | Cathepsin B-Cleavable Cyclopeptidic Chemotherapeutic Prodrugs. | Molecules | 2020 | https://conductscience.org/library/papers/32962018 | PubMed |
| 30174339 | Advanced architectures in the design of responsive polymers for cancer nanomedicine. | J Appl Polym Sci | 2018 | https://conductscience.org/library/papers/30174339 | PubMed |
| 28098511 | Hemodynamic effects of HPMA copolymer based doxorubicin conjugate: A randomized controlled and comparative spectral study in conscious rats. | Nanotoxicology | 2017 | https://conductscience.org/library/papers/28098511 | PubMed |
| 28031879 | Photodynamic therapy and imaging based on tumor-targeted nanoprobe, polymer-conjugated zinc protoporphyrin. | Future Sci OA | 2015 | https://conductscience.org/library/papers/28031879 | PubMed |
| 25529761 | Synthesis and therapeutic effect of styrene-maleic acid copolymer-conjugated pirarubicin. | Cancer Sci | 2015 | https://conductscience.org/library/papers/25529761 | PubMed |
| 24892741 | Cellular uptake and internalization of hyaluronan-based doxorubicin and cisplatin conjugates. | J Drug Target | 2014 | https://conductscience.org/library/papers/24892741 | PubMed |
| 22707853 | Polymeric conjugates for drug delivery. | Chem Mater | 2012 | https://conductscience.org/library/papers/22707853 | PubMed |
| 22400063 | Protease-activated drug development. | Theranostics | 2012 | https://conductscience.org/library/papers/22400063 | PubMed |
| 22278817 | Targeting of multidrug-resistant human ovarian carcinoma cells with anti-P-glycoprotein antibody conjugates. | Macromol Biosci | 2012 | https://conductscience.org/library/papers/22278817 | PubMed |
| 21452893 | Targeted albumin-based nanoparticles for delivery of amphipathic drugs. | Bioconjug Chem | 2011 | https://conductscience.org/library/papers/21452893 | PubMed |
| 20845065 | HPMA copolymer-aminohexylgeldanamycin conjugates targeting cell surface expressed GRP78 in prostate cancer. | Pharm Res | 2010 | https://conductscience.org/library/papers/20845065 | PubMed |
| 19919846 | HPMA copolymers: origins, early developments, present, and future. | Adv Drug Deliv Rev | 2010 | https://conductscience.org/library/papers/19919846 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17869367
GET https://conductscience.org/api/papers/v1/17869367/references?page=2